Informatie:
Fout:
ID
45433
Beschrijving
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Uterine Cervical Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000628 In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample.
Link
Trefwoorden
Versies (1)
- 29-11-22 29-11-22 - Chiara Middel
Houder van rechten
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Geüploaded op
29 november 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000628 Characterization of a Metastatic Cervical Cancer Using NGS
Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Similar models
Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
SAMPLE_ID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
CL Item
Is not a tumor (N)
CL Item
Is Tumor (Y)
PRIMARY_METASTATIC_TUMOR
Item
Primary tumor, metastasis, or transformed cell line
string
C0677930 (UMLS CUI [1,1])
C0027627 (UMLS CUI [2,1])
C0007601 (UMLS CUI [3,1])
C0027627 (UMLS CUI [2,1])
C0007601 (UMLS CUI [3,1])
PRIMARY_TUMOR_LOCATION
Item
Primary tumor location
string
C0475447 (UMLS CUI [1,1])